View in EDS

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE).

Saved in:
Bibliographic Details
Title: Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE).
Authors: Grande, E.1 egrande@oncologiahrc.com, Capdevila, J.2, Castellano, D.3, Teulé, A.4, Durán, I.5, Fuster, J.6, Sevilla, I.7, Escudero, P.8, Sastre, J.9, García-Donas, J.10, Casanovas, O.11, Earl, J.12, Ortega, L.13, Apellaniz-Ruiz, M.14, Rodriguez-Antona, C.14, Alonso-Gordoa, T.1, Díez, J. J.15, Carrato, A.1, García-Carbonero, R.5
Source: Annals of Oncology. Sep2015, Vol. 26 Issue 9, p1987-1993. 7p. 2 Charts, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdv252